CHEBI:134722 - favipiravir

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name favipiravir
ChEBI ID CHEBI:134722
Definition A member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C5H4FN3O2
Net Charge 0
Average Mass 157.104
Monoisotopic Mass 157.02875
InChI InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)
InChIKey ZCGNOVWYSGBHAU-UHFFFAOYSA-N
SMILES NC(=O)C1=NC(F)=CN=C1O
Roles Classification
Biological Role(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
A DNA polymerase inhibitor that interferes with the action of a RNA-directed RNA polymerase (EC 2.7.7.48).
Application(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing favipiravir (CHEBI:134722) has role anticoronaviral agent (CHEBI:149553)
favipiravir (CHEBI:134722) has role antiviral drug (CHEBI:36044)
favipiravir (CHEBI:134722) has role EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor (CHEBI:170010)
favipiravir (CHEBI:134722) is a hydroxypyrazine (CHEBI:71633)
favipiravir (CHEBI:134722) is a organofluorine compound (CHEBI:37143)
favipiravir (CHEBI:134722) is a primary carboxamide (CHEBI:140324)
Incoming favipiravir-RTP (CHEBI:170009) has functional parent favipiravir (CHEBI:134722)
IUPAC Name
6-fluoro-3-hydroxypyrazine-2-carboxamide
INNs Sources
favipiravir WHO MedNet
favipiravir WHO MedNet
favipiravir WHO MedNet
favipiravirum WHO MedNet
Synonyms Sources
6-fluoro-3-hydroxy-2-pyrazinecarboxamide ChemIDplus
fapilavir DrugBank
T 705 ChemIDplus
T-705 ChemIDplus
T705 ChemIDplus
Brand Names Sources
Areplivir ChEBI
Avifavir ChEBI
Avigan KEGG DRUG
Favilavir ChEBI
Favipira ChEBI
Manual Xrefs Databases
431002 ChemSpider
4887 DrugCentral
D09537 KEGG DRUG
DB12466 DrugBank
Favipiravir Wikipedia
View more database links
Registry Numbers Types Sources
259793-96-9 CAS Registry Number ChemIDplus
9697246 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
28105854 PubMed citation Europe PMC
28324644 PubMed citation Europe PMC
28465146 PubMed citation Europe PMC
28769016 PubMed citation Europe PMC
29289664 PubMed citation Europe PMC
29289666 PubMed citation Europe PMC
29369776 PubMed citation Europe PMC
29765101 PubMed citation Europe PMC
29936152 PubMed citation Europe PMC
29982696 PubMed citation Europe PMC
30715325 PubMed citation Europe PMC
30951731 PubMed citation Europe PMC
31195019 PubMed citation Europe PMC
31507197 PubMed citation Europe PMC
31673977 PubMed citation Europe PMC
32174453 PubMed citation Europe PMC
32553844 PubMed citation Europe PMC
32645335 PubMed citation Europe PMC
32834770 PubMed citation Europe PMC
32836314 PubMed citation Europe PMC
32863356 PubMed citation Europe PMC
33108587 PubMed citation Europe PMC
33232871 PubMed citation Europe PMC
33268271 PubMed citation Europe PMC
33418497 PubMed citation Europe PMC
33451007 PubMed citation Europe PMC
33457366 PubMed citation Europe PMC
33478340 PubMed citation Europe PMC
33494498 PubMed citation Europe PMC
33526596 PubMed citation Europe PMC
33649117 PubMed citation Europe PMC
33859168 PubMed citation Europe PMC
PMC7971419 PubMed Central citation Europe PMC
Last Modified
26 April 2021